Brian O’Shaughnessy

Partner, Dinsmore & Shohl LLP and

Past President, Licensing Executives Society, USA & Canada

Brian O’Shaughnessy

Partner, Dinsmore & Shohl LLP and

Past President, Licensing Executives Society, USA & Canada

Brian, past president and chair of the board of the Licensing Executives Society (USA and Canada), Inc. (LES), is an internationally recognized authority in technology licensing agreements and commercial transactions involving intellectual property rights. He is a partner in the Washington DC office of Dinsmore & Shohl LLP, and chair of its IP Transactions and Licensing Group. He counsels clients in the strategic development and utilization of intellectual property portfolios. He represents innovators before the U.S. Patent and Trademark Office, including contested proceedings before the USPTO Patent Trial and Appeal Board; and in the resolution of contested matters before the federal courts and the International Trade Commission. 

His involvement in LES, a non-profit, non-partisan professional society devoted to education, standards development, and public policy in the business applications of intellectual property, spans several decades. He served on the LES Board of Directors 2007 – 2019; and continues to serve LES as senior vice president for public policy. He is a longstanding contributor to LES Education, including serving as chair of its education committee; and as an editor, author and faculty member of its curriculum based education programs. Brian has also served as an LES delegate to LES International, the global network of LES national and regional societies, and chaired several committees for LESI including education and external relations. In 2019, Brian received the LESI President’s Award for Exceptional Service.

Contributions

Deep Dive Episode 177 – Patents and Pandemics: Innovation Policy and the Patent Waiver Petition at the WTO

May 6, 2021

Experts debate the role of patents in medical care and how the US should respond to the petition submitted to the WTO to waive all intellectual property rights on drugs, vaccines, or other responses to the COVID-19 pandemic.

Listen to this podcast

Deep Dive Episode 164 – How Will the Biden Administration Handle China’s Intellectual Property Practices?

February 25, 2021

Experts from across the political spectrum debate the best path forward for the new administration regarding China and intellectual property.

Listen to this podcast

Deep Dive Episode 156 – Incentivizing Drug Development: Patents or Prizes?

January 21, 2021

In this live podcast, experts debate which legal rules and institutions are best-suited to promote the development and commercialization of new drugs and vaccines.

Listen to this podcast

Deep Dive Episode 142 – The United States-China Relationship and Intellectual Property

October 28, 2020

In this live podcast, experts on intellectual property and China discuss whether China’s behaviors constitute a violation of international norms, and what, if anything, the United States should be doing about it.

Listen to this podcast

Deep Dive Episode 118 – Can Patents and Bayh-Dole Fuel Innovation in the Time of COVID-19?

June 25, 2020

In this episode, experts discuss how patents, patent licensing, and the tech transfer process created by the Bayh-Dole Act might provide key legal and policy tools for companies to respond effectively to our current health crisis and crises to come.

Listen to this podcast

Deep Dive Episode 10 – Is There a “Death Squad” at the U.S. Patent Office?: Examining the Patent Trial and Appeal Board

August 18, 2017

Josh Malone (Bunch O Balloons), Kristen Osenga (University of Richmond School of Law), and Brian O’Shaughnessy (Dinsmore & Shohl) discuss the USPTO’s Patent Trial and Appeal Board.

Listen to this podcast